Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor in mice

Cancer Immunology Immunotherapy

Volumn 45, Issue 2, 1997, Pages 100-108

  Lasek, Witold ^a   Feleszko, Wojciech ^a   Gola̧b, Jakub ^a   Stokłosa, Tomasz ^a   Marczak, Maria ^b   Da̧browska, Anna ^a   Malejczyk, Magdalena ^b   Jakóbisiak, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Interleukin 12; TNF ; Tumor immunotherapy

Indexed keywords

INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; LUNG CARCINOMA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA;

ANIMALS; INTERFERON TYPE II; INTERLEUKIN-12; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030719401     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050408     Document Type: Article

References (36)

1. Bellone G, Trinchieri G (1994) Dual stimulatory and inhibitory effect of NKSF/IL-12 on human hematopoiesis. J Immunol 153:930
2. Brouckaert PGG, Leroux-Roels GG, Guisez Y, Tavernier J, Fiers W (1986) In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-γ, on a syngeneic murine melanoma. Int J Cancer 38:763
3. Brunda MJ, Luistro L, Hendrzak JA, Fountoulakis M, Carotta G, Gately MK (1995) Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J Immunother 17:71
4. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G (1991) Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. J Exp Med 173:869
5. Chen L, Suzuki Y, Wheelock EF (1987) Interferon-γ synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages. J Immunol 139:4096
6. Colombo MP Vagliani M, Spreafico F, Parenza M, Chiodoni C, Melani C, Stoppacciaro A (1996) Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 56:2531
7. Coughlin CM, Wysocka M, Kurzawa HL, Lee WMF, Trinchieri G (1995) B7-1 and interleukin-12 synergistically induce effective antitumor immunity. Cancer Res 55:4980
8. Eggermont AMM (1996) Treatment of melanoma in-transit metastases confined to the limb. Cancer Surv 26:335
9. Gately MK, Desai BB, Wolitzky AC, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizzonite R, Gubler U, Stern AS (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147:874
10. Gately MK, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127
11. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR, Murphy M (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 6:157
12. Godfrey DI, Kennedy J, Gately MK, Hakimi J, Hubbard BR, Zlotnik A (1994) IL-12 influences intrathymic T cell development. J Immunol 152:2729
13. Graves DT, Barnhill R, Galanopoulos T, Antoniades HN (1992) Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 140:9
14. Hori K, Ehrke MJ, Mace K, Mihich E (1987) Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and γ-interferon. Cancer Res 47:5868
15. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri B (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827
16. Lasek W, Wańkowicz A, Kuc K, Feleszko W, Gola̧b J, Giermasz A, Wiktor-Jȩdrzejczak W, Jakóbisiak M (1995) Potentiation of antitumor effects of tumor necrosis factor and interteron γ by macrophage-colony-stimulating factor in a MmB 16 melanoma model in mice. Cancer Immunol Immunother 40:315
17. Lasek W, Giermasz A, Kuc K, Wańkowicz A, Feleszko W, Gola̧b J, Zagozdzon R, Stokłosa T, Jakóbisiak M (1996) Potentiation of the antitumor effect of actinomycin D by tumor necrosis factor α in mice: correlation between results of in vitro and in vivo studies. Int J Cancer 66:374
18. Majewski S, Szmurło A, Marczak M, Jabońska S, Bollag W (1994) Synergistic effect of retinoids and interteron γ on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Int J Cancer 57:81
19. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199
20. Mano-Hirano Y, Sato N, Sawasaki Y, Haranaka K, Satomi N, Nariuchi H, Goto T (1987) Inhibition of tumor-induced migration of bovine capillary endothelial cell by mouse and rabbit tumor necrosis factor. J Natl Cancer Inst 78:115
21. Nastala CL, Edington HD, Mckinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153:1697
22. Obana S, Miyazawa H, Hara E, Tamura T, Nariuchi H, Takata M, Fujimoto S, Yamamoto H (1995) Induction of anti-tumor immunity by mouse tumor cells transfected with mouse interleukin-12 gene. Jpn J Med Sci Biol 48:221
23. Sanceau J, Merlin G, Wietzerbin J (1992) Tumor necrosis factor-α and IL-6 up-regulate IFN-γ receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J Immunol 149:1671
24. Sato N, Goto T, Haranaka K, Satomi N, Nariuchi H, Hirano Y, Sawasaki Y (1986) Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst 76:1113
25. Sgadari C, Angiolillo AL, Tosato G (1996) Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87:3877
26. Shimomuru K, Manda T, Mukumoto S, Kobayashi K, Nakano K, Mori J (1988) Recombinant human tumor necrosis factor-α: thrombus formation is a cause of anti-tumor activity. Int J Cancer 41:243
27. Sidhu RS, Bollon AP (1993) Tumor necrosis factor activities and cancer therapy - a perspective. Pharmacol Ther 57:79
28. Sidky YA, Auerbach R (1975) Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reactiom. J Exp Med 141:1084
29. Stern AS, Podlaski FJ, Hulmes, JD, Pan Y-C, Quinn PM, Wolitzky AG, Familetti PC, Stremlo DL, Trutti T, Chizzonite R, Gately MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lympho-blastoid cells. Proc Natl Acad Sci USA 87:6808
30. Sugarman BJ, Aggarval BB, Hass PE, Figari IS, Palladino MA Jr, Shepard HM (1985) Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943
31. Teicher BA, Ara G, Menon K, Schaub RG (1996) In vivo studies with interleukin-12 alone and in combination with monocyte colony-stimulating factor and/or fractionated radiation treatment. Int J Cancer 65:80
32. Tripp CS, Wolf SF, Unanuc ER (1993) Interleukin 12 and tumor necrosis factor α are costimulators of Interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interlcukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725
33. Tsujimoto M, Yip YK, Vilcek J (1986) Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136:2441
34. Voest EE, Kenyon BM, O'reilly MS, Truitt G, D'amato RJ, Folkman J (1995) Inhibition ol'angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87:581
35. Wigginton JM, Komschlies KL, Back TC, Franco JL, Brunda MJ, Wiltrout RH (1996) Administration of interleukin-12 with pulse interleukin-2 and the rapid and complete eradication of murine renal carcinoma. J Natl Cancer Inst 88:38
36. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT (1995) Cancer immunotherapy of established tumors with IL-12. J Immunol 155:1393